Viatris Agrees to Acquire Pacira BioSciences for $1.65 billion in Cash, Becoming a Leader in Non-Opioid Pain Therapies
On Oct. 8, 2026, Viatris, a global healthcare company, and Pacira BioSciences, a leader in innovative non-opioid pain…
-
-
Atlas of the brain’s striatum could guide researchers to new drug treatments
On Sept. 1, 2026, Massachusetts Institute of Technology (MIT) researchers release a study that reveals insights into populations…
-
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
On Jun. 16, 2026, the U.S. Food and Drug Administration (FDA) approved another over-the-counter (OTC) intranasal naloxone product,…
